SCHEMBL5086761

SCHEMBL5086761

C1CCC(C2(C3CCCCC3)CNCC[N]2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL27294343 0.62
SCHEMBL4920900 0.62 SOS1 (0.30)
SCHEMBL18019792 0.60 MAPT (0.36)
SCHEMBL17472486 0.60 MAPT (0.36)
SCHEMBL27415101 0.60
SCHEMBL21022710 0.60 SIGMAR1 (0.31)
SCHEMBL4926510 0.58
SCHEMBL194227 0.58
SCHEMBL9169515 0.58
SCHEMBL14532454 0.56 OPRM1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7375081-B2 Therapeutic combination of a pneumocandin derivative and an antifungal agent ASTELLAS PHARMA INC. (JP) 2008-05-20 US claimed
US-6875740-B1 Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-04-05 US claimed